Molecular Therapy: Oncology Pharmacology (medical)
Reversible control of CAR T cells through PROTAC compound targeting bromodomain mutant
The publisher did not provide an abstract — full text is available via the link below.
Molecular Therapy: Oncology Pharmacology (medical)
The publisher did not provide an abstract — full text is available via the link below.